All In Biotech

Drug Trial Radar · NCT02278367

Clinical Evaluation of Flortaucipir F 18

Clinical Evaluation of 18F-AV-1451

Last checked: Nov 20, 2026Latest source record: Sep 10, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

179

Actual

Start

Dec 2014

Primary completion

Jun 26, 2019

Study completion Jun 26, 2019

Sponsor

Lead sponsor
Avid RadiopharmaceuticalsIndustry
Sponsor type
Industry
First posted
Oct 30, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is designed to expand the database of flortaucipir F 18 safety and tau binding as measured by PET imaging and to provide standardized conditions for flortaucipir PET use, data collection and analysis to facilitate companion studies including, but not limited to, longitudinal studies of aging, depression, and traumatic brain injury.

Conditions

  • Alzheimer's Disease
  • Traumatic Brain Injury
  • Depression

Interventions

  • Flortaucipir F18Drug

    IV injection, 370 MBq (10 mCi), up to two doses

  • Brain PET scanProcedure

    positron emission tomography (PET) scan of the brain

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Adverse Events Related to Flortaucipir AdministrationTime frame: within 48 hours of drug administration
  2. Flortaucipir PET Scan SUVrTime frame: baseline and follow-up scans

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Banner Alzheimer's Institute

    Phoenix, Arizona

  • Yale University

    New Haven, Connecticut

  • Cleveland Clinic Lou Ruvo Center for Brain Health

    Las Vegas, Nevada

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Center for Vital Longevity at the University of Texas at Dallas

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.